GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Receivables Turnover

Steminent Biotherapeutics (ROCO:7729) Receivables Turnover : 0.00 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Steminent Biotherapeutics's Revenue for the six months ended in Dec. 2024 was NT$0.00 Mil. Steminent Biotherapeutics's average Accounts Receivable for the six months ended in Dec. 2024 was NT$0.00 Mil.

Steminent Biotherapeutics Receivables Turnover Historical Data

The historical data trend for Steminent Biotherapeutics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics Receivables Turnover Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Receivables Turnover
- - - - -

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Receivables Turnover Get a 7-Day Free Trial - 1.94 - - -

Competitive Comparison of Steminent Biotherapeutics's Receivables Turnover

For the Biotechnology subindustry, Steminent Biotherapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steminent Biotherapeutics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's Receivables Turnover falls into.


;
;

Steminent Biotherapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Steminent Biotherapeutics's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Receivables Turnover (A: Dec. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2024 ) / ((Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

Steminent Biotherapeutics's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

Receivables Turnover (Q: Dec. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2024 ) / ((Accounts Receivable (Q: Jun. 2024 ) + Accounts Receivable (Q: Dec. 2024 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steminent Biotherapeutics  (ROCO:7729) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Steminent Biotherapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Steminent Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » Receivables Turnover
Comparable Companies
ROCO:4186 ROCO:7814 ROCO:7790 ROCO:6879 ROCO:4195 ROCO:4131 ROCO:6564 ROCO:6810 ROCO:6850 ROCO:6236 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Website
http://www.steminent.com
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines